Palisade Bio (PALI) EBITDA Margin (2011 - 2026)
Palisade Bio (PALI) posted EBITDA Margin of -2339.60% for Q2 2026.
Powered by 
Analysis
Palisade Bio (PALI) EBITDA Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Palisade Bio was -7069.60%; for FY2023, it was -5226.40%.
- Annual EBITDA Margin shows a five-year change of -2121.15 percentage points (FY2018 to FY2023).
- In prior years, Palisade Bio's EBITDA Margin was -68742.60% in FY2020 (-13605.31 pp) and -55137.29% in FY2019 (-52032.04 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 39.16% |
| 10 | Palisade Bio | 299.11 Mn | -97.33 Mn | - | -2,339.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,339.60% |
| Mar 31, 2023 | -1,011.20% |
| Dec 31, 2020 | -129,760.00% |
| Sep 30, 2020 | -72,600.00% |
| Jun 30, 2020 | -74,763.12% |
| Mar 31, 2020 | -32,581.16% |
| Dec 31, 2019 | -84,097.96% |
| Sep 30, 2019 | -83,503.64% |
| Jun 30, 2019 | -23,828.87% |
| Mar 31, 2019 | -96,669.76% |
| Dec 31, 2018 | -71,179.04% |
| Sep 30, 2018 | -81,460.88% |
| Jun 30, 2018 | -782.59% |
| Mar 31, 2018 | -91,264.84% |
| Dec 31, 2017 | -876.58% |
| Sep 30, 2017 | -101,394.80% |
| Jun 30, 2017 | -165,508.92% |
| Mar 31, 2017 | -162,885.92% |
| Dec 31, 2016 | -63,177.74% |
| Sep 30, 2016 | -189,590.44% |
API Access
Palisade Bio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();